Business Context and Reporting Period
Launch One Acquisition Corp. (LPAA) is a Cayman Islands exempted company and a Special Purpose Acquisition Company (SPAC) formed to effect a business combination. The filing covers the quarterly period ended March 31, 2026. The Company is an emerging growth company and a shell company. As of the filing date, the Company had not commenced any operations other than identifying and negotiating a target for a business combination.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Income | $1,700,072 | $2,287,413 |
| Operating Expenses (G&A) | $467,775 | $178,042 |
| Interest Income (Trust Account) | $2,167,844 | $2,449,036 |
| Cash (Operating) | $266,001 | $668,923 |
| Trust Account Balance | $247,617,197 | $245,449,353 |
| Working Capital Deficit | ($1,077,733) | N/A |
| Debt (Working Capital Note) | $500,000 | $0 |
| Deferred Underwriting Fee | $10,950,000 | $10,950,000 |
Material Changes vs. Prior Period
- Operating Expenses: General and administrative expenses increased significantly to $467,775 from $178,042 in the prior year quarter, reflecting increased costs associated with the search for a business combination.
- Net Income: Net income decreased to $1.70 million from $2.29 million, primarily due to lower interest income earned on the Trust Account and higher operating expenses.
- Liquidity: Operating cash decreased from $30,146 at year-end 2025 to $266,001 at March 31, 2026, aided by a new $500,000 Working Capital Note. However, the Company reported a working capital deficit of approximately $1.08 million.
- Debt: The Company incurred $500,000 in debt via a new Working Capital Note issued to the Sponsor in March 2026, whereas no such debt existed in the prior period.
Outlook, Risks, and Management Commentary
- Business Combination Status: On January 30, 2026, the Company terminated its Business Combination Agreement with Minovia Therapeutics Ltd. The Company is currently seeking alternative targets to consummate an initial business combination.
- Deadline: The Company must complete a business combination by July 15, 2026 (24 months from IPO). Failure to do so will result in mandatory liquidation and redemption of public shares.
- Going Concern: Management has raised substantial doubt about the Company's ability to continue as a going concern due to limited operating cash and the mandatory liquidation deadline. The Company may need to raise additional capital or secure further loans from the Sponsor.
- Financing: A new Working Capital Note allows for up to $1,000,000 in loans from the Sponsor. The initial tranche of $500,000 carries an 8% annual interest rate (26% default rate) and a 20% original issue discount. The Sponsor has pledged approximately 51% of its Founder Shares as collateral for this facility.
- Trust Account: The Trust Account holds approximately $10.77 per public share. Interest earned is used to pay taxes and may be withdrawn for working capital, but the principal is reserved for the business combination or redemption.
Investor Verification Checklist
- Verify the timeline for identifying a new target company given the July 15, 2026, liquidation deadline.
- Confirm the terms and repayment conditions of the $500,000 Working Capital Note and the potential for additional tranches.
- Assess the sufficiency of the $266,001 operating cash balance to fund operations until a deal is closed or liquidation occurs.
- Review the redemption value per share ($10.77) versus the current market price to evaluate potential redemption risk.
- Monitor the status of the Sponsor's pledged Founder Shares and the implications of the Credit Agreement with Keystone Capital Partners.